| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | proline-rich region binding | 1.78e-04 | 21 | 19 | 2 | GO:0070064 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle G1/S phase transition | 4.40e-05 | 80 | 18 | 3 | GO:1902808 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle phase transition | 2.32e-04 | 140 | 18 | 3 | GO:1901989 | |
| GeneOntologyBiologicalProcess | mRNA processing | 1.14e-03 | 551 | 18 | 4 | GO:0006397 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 1.20e-03 | 246 | 18 | 3 | GO:1902806 | |
| GeneOntologyBiologicalProcess | positive regulation of G1/S transition of mitotic cell cycle | 1.40e-03 | 64 | 18 | 2 | GO:1900087 | |
| GeneOntologyCellularComponent | nuclear speck | 5.40e-04 | 431 | 19 | 4 | GO:0016607 | |
| MousePheno | embryonic lethality before implantation | 1.35e-04 | 242 | 16 | 4 | MP:0006204 | |
| Domain | RRM_1 | 1.50e-02 | 208 | 17 | 2 | PF00076 | |
| Domain | RRM | 1.63e-02 | 217 | 17 | 2 | SM00360 | |
| Domain | RRM_dom | 1.77e-02 | 227 | 17 | 2 | IPR000504 | |
| Domain | RRM | 1.82e-02 | 230 | 17 | 2 | PS50102 | |
| Domain | - | 2.03e-02 | 244 | 17 | 2 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 2.26e-02 | 258 | 17 | 2 | IPR012677 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.80e-08 | 954 | 19 | 8 | 36373674 | |
| Pubmed | 5.57e-08 | 403 | 19 | 6 | 35253629 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 3.72e-07 | 1415 | 19 | 8 | 28515276 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 5.50e-07 | 989 | 19 | 7 | 36424410 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 3.21e-06 | 807 | 19 | 6 | 22681889 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 4.24e-06 | 847 | 19 | 6 | 35235311 | |
| Pubmed | 5.12e-06 | 215 | 19 | 4 | 35973513 | ||
| Pubmed | 6.28e-06 | 506 | 19 | 5 | 30890647 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.49e-05 | 605 | 19 | 5 | 28977666 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.51e-05 | 283 | 19 | 4 | 30585729 | |
| Pubmed | 1.91e-05 | 1103 | 19 | 6 | 34189442 | ||
| Pubmed | 2.15e-05 | 653 | 19 | 5 | 22586326 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 2.41e-05 | 1149 | 19 | 6 | 35446349 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 2.43e-05 | 670 | 19 | 5 | 22990118 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 2.82e-05 | 332 | 19 | 4 | 32786267 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 3.13e-05 | 341 | 19 | 4 | 32971831 | |
| Pubmed | 3.16e-05 | 708 | 19 | 5 | 39231216 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 3.52e-05 | 724 | 19 | 5 | 36232890 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 3.99e-05 | 1257 | 19 | 6 | 36526897 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 5.19e-05 | 1318 | 19 | 6 | 30463901 | |
| Pubmed | 5.77e-05 | 399 | 19 | 4 | 35987950 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 6.01e-05 | 1353 | 19 | 6 | 29467282 | |
| Pubmed | 6.47e-05 | 1371 | 19 | 6 | 36244648 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 6.96e-05 | 148 | 19 | 3 | 32538781 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 7.83e-05 | 857 | 19 | 5 | 25609649 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 8.02e-05 | 1425 | 19 | 6 | 30948266 | |
| Pubmed | 8.42e-05 | 25 | 19 | 2 | 15456888 | ||
| Pubmed | 8.42e-05 | 25 | 19 | 2 | 9731529 | ||
| Pubmed | 8.50e-05 | 441 | 19 | 4 | 31239290 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 8.72e-05 | 444 | 19 | 4 | 34795231 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 9.27e-05 | 163 | 19 | 3 | 22113938 | |
| Pubmed | 1.01e-04 | 1487 | 19 | 6 | 33957083 | ||
| Pubmed | 1.05e-04 | 1497 | 19 | 6 | 31527615 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.13e-04 | 475 | 19 | 4 | 31040226 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.17e-04 | 934 | 19 | 5 | 33916271 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.22e-04 | 179 | 19 | 3 | 36261009 | |
| Pubmed | 1.73e-04 | 1014 | 19 | 5 | 32416067 | ||
| Pubmed | 1.82e-04 | 538 | 19 | 4 | 28524877 | ||
| Pubmed | Gene essentiality and synthetic lethality in haploid human cells. | 2.53e-04 | 229 | 19 | 3 | 26472760 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.56e-04 | 588 | 19 | 4 | 38580884 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.57e-04 | 1105 | 19 | 5 | 35748872 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 2.89e-04 | 607 | 19 | 4 | 39147351 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.91e-04 | 608 | 19 | 4 | 36089195 | |
| Pubmed | 3.27e-04 | 250 | 19 | 3 | 33536335 | ||
| Pubmed | 3.30e-04 | 251 | 19 | 3 | 28077445 | ||
| Pubmed | 3.97e-04 | 660 | 19 | 4 | 32780723 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 4.13e-04 | 271 | 19 | 3 | 32433965 | |
| Pubmed | 4.28e-04 | 56 | 19 | 2 | 19299420 | ||
| Pubmed | 4.43e-04 | 57 | 19 | 2 | 38223760 | ||
| Pubmed | Genetic variants associated with breast size also influence breast cancer risk. | 4.43e-04 | 57 | 19 | 2 | 22747683 | |
| Pubmed | 5.08e-04 | 61 | 19 | 2 | 20305087 | ||
| Interaction | SMC5 interactions | 5.82e-07 | 1000 | 17 | 8 | int:SMC5 | |
| Interaction | CDK8 interactions | 8.61e-07 | 222 | 17 | 5 | int:CDK8 | |
| Interaction | ZNF330 interactions | 1.14e-06 | 446 | 17 | 6 | int:ZNF330 | |
| Interaction | DDX23 interactions | 1.75e-06 | 480 | 17 | 6 | int:DDX23 | |
| Interaction | WBP4 interactions | 1.83e-06 | 109 | 17 | 4 | int:WBP4 | |
| Interaction | E2F4 interactions | 3.46e-06 | 540 | 17 | 6 | int:E2F4 | |
| Interaction | TERF2IP interactions | 3.93e-06 | 552 | 17 | 6 | int:TERF2IP | |
| Interaction | POLR1E interactions | 8.00e-06 | 350 | 17 | 5 | int:POLR1E | |
| Interaction | TTC33 interactions | 9.54e-06 | 50 | 17 | 3 | int:TTC33 | |
| Interaction | MEN1 interactions | 1.10e-05 | 1029 | 17 | 7 | int:MEN1 | |
| Interaction | SLFN11 interactions | 1.13e-05 | 376 | 17 | 5 | int:SLFN11 | |
| Interaction | IFI16 interactions | 1.71e-05 | 714 | 17 | 6 | int:IFI16 | |
| Interaction | DNAJC8 interactions | 3.50e-05 | 230 | 17 | 4 | int:DNAJC8 | |
| Interaction | HAPSTR1 interactions | 3.99e-05 | 829 | 17 | 6 | int:HAPSTR1 | |
| Interaction | POLR1G interactions | 4.01e-05 | 489 | 17 | 5 | int:POLR1G | |
| Interaction | H3C1 interactions | 6.36e-05 | 901 | 17 | 6 | int:H3C1 | |
| Interaction | HNRNPCL2 interactions | 6.92e-05 | 274 | 17 | 4 | int:HNRNPCL2 | |
| Interaction | SIRPA interactions | 7.66e-05 | 100 | 17 | 3 | int:SIRPA | |
| Interaction | H2BC8 interactions | 8.72e-05 | 576 | 17 | 5 | int:H2BC8 | |
| Interaction | H2AB2 interactions | 9.37e-05 | 107 | 17 | 3 | int:H2AB2 | |
| Interaction | CEBPB interactions | 9.75e-05 | 1443 | 17 | 7 | int:CEBPB | |
| Interaction | EFTUD2 interactions | 1.00e-04 | 1449 | 17 | 7 | int:EFTUD2 | |
| Interaction | CIT interactions | 1.01e-04 | 1450 | 17 | 7 | int:CIT | |
| Interaction | CHAF1A interactions | 1.29e-04 | 322 | 17 | 4 | int:CHAF1A | |
| Interaction | SNRNP40 interactions | 1.40e-04 | 637 | 17 | 5 | int:SNRNP40 | |
| Interaction | NUP50 interactions | 1.61e-04 | 341 | 17 | 4 | int:NUP50 | |
| Interaction | CDK9 interactions | 1.97e-04 | 685 | 17 | 5 | int:CDK9 | |
| Interaction | ACTC1 interactions | 2.09e-04 | 694 | 17 | 5 | int:ACTC1 | |
| Interaction | SRP14 interactions | 2.11e-04 | 366 | 17 | 4 | int:SRP14 | |
| Interaction | BOD1L1 interactions | 2.50e-04 | 149 | 17 | 3 | int:BOD1L1 | |
| Interaction | SNRPF interactions | 2.56e-04 | 385 | 17 | 4 | int:SNRPF | |
| Interaction | GRWD1 interactions | 2.69e-04 | 390 | 17 | 4 | int:GRWD1 | |
| Interaction | SIRT7 interactions | 2.89e-04 | 744 | 17 | 5 | int:SIRT7 | |
| Interaction | H3-3A interactions | 2.98e-04 | 749 | 17 | 5 | int:H3-3A | |
| Interaction | PRPF8 interactions | 3.51e-04 | 776 | 17 | 5 | int:PRPF8 | |
| Interaction | TCEANC2 interactions | 3.70e-04 | 34 | 17 | 2 | int:TCEANC2 | |
| Interaction | CEBPA interactions | 3.76e-04 | 1245 | 17 | 6 | int:CEBPA | |
| Interaction | SRP9 interactions | 3.80e-04 | 427 | 17 | 4 | int:SRP9 | |
| Interaction | ABCE1 interactions | 3.94e-04 | 431 | 17 | 4 | int:ABCE1 | |
| Interaction | HSPH1 interactions | 4.56e-04 | 448 | 17 | 4 | int:HSPH1 | |
| Interaction | H2BC26 interactions | 4.56e-04 | 183 | 17 | 3 | int:H2BC26 | |
| Interaction | BAP1 interactions | 5.03e-04 | 1314 | 17 | 6 | int:BAP1 | |
| Interaction | PARP1 interactions | 5.07e-04 | 1316 | 17 | 6 | int:PARP1 | |
| Interaction | STK26 interactions | 5.25e-04 | 192 | 17 | 3 | int:STK26 | |
| Interaction | BIRC3 interactions | 5.46e-04 | 1334 | 17 | 6 | int:BIRC3 | |
| Interaction | WIPF2 interactions | 5.93e-04 | 43 | 17 | 2 | int:WIPF2 | |
| Interaction | KCNA3 interactions | 5.97e-04 | 871 | 17 | 5 | int:KCNA3 | |
| Interaction | SNRPA interactions | 6.00e-04 | 482 | 17 | 4 | int:SNRPA | |
| Interaction | RPS6 interactions | 6.07e-04 | 874 | 17 | 5 | int:RPS6 | |
| Interaction | ADARB1 interactions | 6.34e-04 | 489 | 17 | 4 | int:ADARB1 | |
| Interaction | NR2C2 interactions | 7.14e-04 | 1403 | 17 | 6 | int:NR2C2 | |
| Interaction | H1-1 interactions | 7.26e-04 | 507 | 17 | 4 | int:H1-1 | |
| Interaction | SNRPB interactions | 7.81e-04 | 517 | 17 | 4 | int:SNRPB | |
| Interaction | PML interactions | 8.17e-04 | 933 | 17 | 5 | int:PML | |
| Interaction | FOXK2 interactions | 8.32e-04 | 225 | 17 | 3 | int:FOXK2 | |
| Interaction | CPSF6 interactions | 8.33e-04 | 526 | 17 | 4 | int:CPSF6 | |
| Interaction | EED interactions | 8.35e-04 | 1445 | 17 | 6 | int:EED | |
| Interaction | CHD4 interactions | 8.37e-04 | 938 | 17 | 5 | int:CHD4 | |
| Interaction | ZC3H3 interactions | 8.43e-04 | 226 | 17 | 3 | int:ZC3H3 | |
| Interaction | ANXA5 interactions | 8.53e-04 | 227 | 17 | 3 | int:ANXA5 | |
| Interaction | POLR2A interactions | 8.94e-04 | 536 | 17 | 4 | int:POLR2A | |
| Interaction | H2AC17 interactions | 9.09e-04 | 232 | 17 | 3 | int:H2AC17 | |
| Interaction | CD2BP2 interactions | 9.09e-04 | 232 | 17 | 3 | int:CD2BP2 | |
| Interaction | SKIC8 interactions | 9.90e-04 | 239 | 17 | 3 | int:SKIC8 | |
| Interaction | MAPK11 interactions | 1.00e-03 | 56 | 17 | 2 | int:MAPK11 | |
| Interaction | NAA40 interactions | 1.01e-03 | 978 | 17 | 5 | int:NAA40 | |
| Interaction | SF3B3 interactions | 1.04e-03 | 558 | 17 | 4 | int:SF3B3 | |
| Interaction | SRSF1 interactions | 1.12e-03 | 570 | 17 | 4 | int:SRSF1 | |
| Interaction | NOP56 interactions | 1.12e-03 | 570 | 17 | 4 | int:NOP56 | |
| Interaction | PUM3 interactions | 1.18e-03 | 254 | 17 | 3 | int:PUM3 | |
| Interaction | SNRPB2 interactions | 1.19e-03 | 255 | 17 | 3 | int:SNRPB2 | |
| Interaction | EIF3I interactions | 1.23e-03 | 258 | 17 | 3 | int:EIF3I | |
| Interaction | SUMO2 interactions | 1.29e-03 | 591 | 17 | 4 | int:SUMO2 | |
| Interaction | EIF3C interactions | 1.30e-03 | 263 | 17 | 3 | int:EIF3C | |
| Interaction | USP36 interactions | 1.35e-03 | 599 | 17 | 4 | int:USP36 | |
| Interaction | GEMIN5 interactions | 1.36e-03 | 267 | 17 | 3 | int:GEMIN5 | |
| Interaction | PSMD7 interactions | 1.41e-03 | 270 | 17 | 3 | int:PSMD7 | |
| Interaction | ARID5B interactions | 1.43e-03 | 67 | 17 | 2 | int:ARID5B | |
| Interaction | SF3A2 interactions | 1.45e-03 | 273 | 17 | 3 | int:SF3A2 | |
| Interaction | NUP43 interactions | 1.58e-03 | 625 | 17 | 4 | int:NUP43 | |
| Interaction | NOP53 interactions | 1.69e-03 | 288 | 17 | 3 | int:NOP53 | |
| Interaction | FBL interactions | 1.71e-03 | 639 | 17 | 4 | int:FBL | |
| Interaction | PURA interactions | 1.74e-03 | 291 | 17 | 3 | int:PURA | |
| Interaction | TCOF1 interactions | 1.76e-03 | 292 | 17 | 3 | int:TCOF1 | |
| Interaction | MSL1 interactions | 1.79e-03 | 75 | 17 | 2 | int:MSL1 | |
| Interaction | ZRSR2 interactions | 1.89e-03 | 77 | 17 | 2 | int:ZRSR2 | |
| Interaction | SNRPA1 interactions | 1.90e-03 | 300 | 17 | 3 | int:SNRPA1 | |
| Interaction | PSMA6 interactions | 1.99e-03 | 305 | 17 | 3 | int:PSMA6 | |
| Interaction | H1-2 interactions | 2.00e-03 | 666 | 17 | 4 | int:H1-2 | |
| Interaction | ZNF2 interactions | 2.04e-03 | 80 | 17 | 2 | int:ZNF2 | |
| Interaction | CDX1 interactions | 2.04e-03 | 80 | 17 | 2 | int:CDX1 | |
| Interaction | MIER1 interactions | 2.04e-03 | 80 | 17 | 2 | int:MIER1 | |
| Interaction | RPL7A interactions | 2.14e-03 | 679 | 17 | 4 | int:RPL7A | |
| Interaction | PRKCI interactions | 2.15e-03 | 313 | 17 | 3 | int:PRKCI | |
| Interaction | RPL31 interactions | 2.15e-03 | 680 | 17 | 4 | int:RPL31 | |
| Interaction | NUPR1 interactions | 2.19e-03 | 683 | 17 | 4 | int:NUPR1 | |
| Interaction | FZR1 interactions | 2.27e-03 | 1172 | 17 | 5 | int:FZR1 | |
| Interaction | DDX60 interactions | 2.29e-03 | 85 | 17 | 2 | int:DDX60 | |
| Interaction | H2BC12 interactions | 2.33e-03 | 322 | 17 | 3 | int:H2BC12 | |
| Interaction | RUNX1 interactions | 2.37e-03 | 324 | 17 | 3 | int:RUNX1 | |
| Cytoband | 2p23.3 | 3.64e-04 | 68 | 19 | 2 | 2p23.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 1.73e-03 | 149 | 19 | 2 | chr2p23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 1.26e-02 | 415 | 19 | 2 | chr12q24 | |
| GeneFamily | RNA binding motif containing | 3.69e-03 | 213 | 8 | 2 | 725 | |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | 1.51e-05 | 458 | 19 | 5 | M40010 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | 6.05e-05 | 612 | 19 | 5 | M4772 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 | 8.45e-05 | 19 | 19 | 2 | M13194 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 1.48e-04 | 384 | 19 | 4 | M1865 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 1.76e-04 | 402 | 19 | 4 | MM1248 | |
| Coexpression | PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN | 2.05e-04 | 161 | 19 | 3 | M2365 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC2 | 2.44e-04 | 32 | 19 | 2 | M2334 | |
| Coexpression | GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP | 2.49e-04 | 172 | 19 | 3 | M2963 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN | 3.82e-04 | 199 | 19 | 3 | M3626 | |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_DN | 3.82e-04 | 199 | 19 | 3 | M7842 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP | 3.88e-04 | 200 | 19 | 3 | M4601 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_DN | 3.88e-04 | 200 | 19 | 3 | M9950 | |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN | 3.88e-04 | 200 | 19 | 3 | M8427 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN | 3.88e-04 | 200 | 19 | 3 | M9310 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_UP | 3.88e-04 | 200 | 19 | 3 | M8868 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_DN | 3.88e-04 | 200 | 19 | 3 | M4044 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN | 3.88e-04 | 200 | 19 | 3 | M6583 | |
| Coexpression | LUI_THYROID_CANCER_PAX8_PPARG_UP | 5.06e-04 | 46 | 19 | 2 | M4381 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | 1.44e-06 | 1187 | 17 | 8 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2 | 1.86e-05 | 1175 | 17 | 7 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500 | 6.57e-05 | 1429 | 17 | 7 | facebase_RNAseq_e8.5_ParaxMesoderm_2500 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K3 | 3.01e-04 | 1259 | 17 | 6 | facebase_RNAseq_e9.5_MandArch_2500_K3 | |
| Disease | alcohol consumption measurement | 5.96e-03 | 1242 | 18 | 4 | EFO_0007878 | |
| Disease | Colorectal Carcinoma | 8.38e-03 | 702 | 18 | 3 | C0009402 | |
| Disease | Lung Neoplasms | 1.12e-02 | 265 | 18 | 2 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.13e-02 | 266 | 18 | 2 | C0242379 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEEEEEEKEEEMVVL | 116 | A0A3B3IU63 | |
| MDPKAAEEEEEEEEE | 266 | P24385 | |
| AKMEEEEEEEEEEEE | 711 | Q9Y4C8 | |
| EEEEEEEEEMPSKDP | 696 | Q8IVL6 | |
| EIMEMEEEKEEREEE | 316 | Q4G1C9 | |
| PDDEEEKEEDEEEKE | 801 | Q6ZMV5 | |
| LENHEPEEEEEEEME | 371 | Q8N7H5 | |
| PEEEEEEEMETEEKE | 376 | Q8N7H5 | |
| RMEEEEEGEEEEEEE | 776 | Q7Z591 | |
| PAQEEEMEEEEEEEE | 451 | Q04637 | |
| EQEEEEDDEEEMEEK | 581 | Q13206 | |
| EDEEEEEEEKEMPSP | 136 | Q52MB2 | |
| EVKENPEEEEEEEEE | 526 | O60841 | |
| AEEDDEEEEEEMMVP | 301 | O15355 | |
| GMLEEEEDEDEEEEE | 986 | Q93073 | |
| EEEEEEEEEMVAEES | 1186 | Q9UPS6 | |
| EEVEMEVESDEEDDK | 321 | Q15459 | |
| EMEEDLGEDEEEEEE | 131 | Q99856 | |
| EIKEEPKEEEMTEEE | 501 | O14776 | |
| MKDEPEVEEEEEEEE | 641 | Q9BWU0 |